Form 6-K Cardiol Therapeutics For: Sep 14

 

 

UNITED STATES 

SECURITIES AND EXCHANGE COMMISSION 

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of September 2026

 

Commission File Number:  001-40712

 

Cardiol Therapeutics Inc. 

(Name of registrant)

 

602-2265 Upper Middle Road East 

Oakville, Ontario L6H 0G5 

Canada

(Address of principal executive office)

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

¨   Form 20-F

x   Form 40-F

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

	CARDIOL THERAPEUTICS INC.
	(Registrant)
Date:  September 14, 2026	By:	/s/ Christopher Waddick
		Name:	Christopher Waddick
		Title:	Chief Financial Officer

 

 

Form 6-K Exhibit Index

 

Exhibit Number		Document Description
99.1		Code of Conduct and Ethics

 

 

ATTACHMENTS / EXHIBITS

EXHIBIT 99.1

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• New Cryptocurrency to Watch: Remittix Nears $33 Million as AVAX Trades Near $10 and Utility Takes Centre Stage
• NEAR Price Today: NEAR Pulls Back Near $5 After Its Rally as Remittix’s $0.28 Entry Sets Up a Fresh Comparison
• Tron Price Prediction: Tron Inc. Files a $200M Share Offering as Remittix Approaches Its November Token Debut